Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy
Conditions
- Lymphoma
- Myeloma
- Cytokine Release Syndrome
- Immune Effector Cell Associated Neurotoxicity Syndrome
Interventions
- DEVICE: Home Automated Telemanagement (HAT) Patient Unit
Sponsor
University of Utah
Collaborators